BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Penagini R. Bile reflux and oesophagitis. Eur J Gastroenterol Hepatol. 2001;13:1-3. [PMID: 11204802 DOI: 10.1097/00042737-200101000-00001] [Cited by in Crossref: 15] [Cited by in F6Publishing: 12] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang C, Liu ZK, Yu PW. Effects of bile reflux and intragastric microflora changes on lesions of remnant gastric mucosa after gastric operation. World J Gastroenterol 2004; 10(10): 1537-1539 [PMID: 15133869 DOI: 10.3748/wjg.v10.i10.1537] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.4] [Reference Citation Analysis]
2 Jiang M, Chen J, Chen F, Yu J, Liang J, Zhang Y, Ou B. Bile and acid reflux in the pathogenesis of reflux oesophagitis in children. J Paediatr Child Health 2009;45:64-7. [PMID: 19208069 DOI: 10.1111/j.1440-1754.2008.01431.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Orel R, Vidmar G. Do acid and bile reflux into the esophagus simultaneously? Temporal relationship between duodenogastro-esophageal reflux and esophageal pH. Pediatr Int. 2007;49:226-231. [PMID: 17445043 DOI: 10.1111/j.1442-200x.2007.02338.x] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
4 Brillantino A, Monaco L, Schettino M, Torelli F, Izzo G, Cosenza A, Marano L, Di Martino N. Prevalence of pathological duodenogastric reflux and the relationship between duodenogastric and duodenogastrooesophageal reflux in chronic gastrooesophageal reflux disease. Eur J Gastroenterol Hepatol 2008;20:1136-43. [PMID: 18946360 DOI: 10.1097/MEG.0b013e32830aba6d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
5 Penagini R, Carmagnola S, Cantu P. Gastro-oesophageal reflux disease - pathophysiological issues of clinical relevance: REVIEW: PATHOPHYSIOLOGICAL ISSUES IN GERD. Alimentary Pharmacology & Therapeutics 2002;16:65-71. [DOI: 10.1046/j.1365-2036.16.s4.10.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 1.0] [Reference Citation Analysis]
6 Frieling T. [Antireflux therapy--more than acid reduction?]. Internist (Berl) 2004;45:1364-9. [PMID: 15480522 DOI: 10.1007/s00108-004-1291-7] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
7 Campanella J, Biagi F, Bianchi PI, Zanellati G, Marchese A, Corazza GR. Clinical response to gluten withdrawal is not an indicator of coeliac disease. Scand J Gastroenterol. 2008;43:1311-1314. [PMID: 18609173 DOI: 10.1080/00365520802200036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.8] [Reference Citation Analysis]
8 Jiang JX, Liu Q, Mao XY, Zhang HH, Zhang GX, Xu SF. Downward trend in the prevalence of Helicobacter pylori infections and corresponding frequent upper gastrointestinal diseases profile changes in Southeastern China between 2003 and 2012. Springerplus 2016;5:1601. [PMID: 27652174 DOI: 10.1186/s40064-016-3185-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
9 Orel R, Markovic S. Bile in the Esophagus: A Factor in the Pathogenesis of Reflux Esophagitis in Children: . Journal of Pediatric Gastroenterology and Nutrition 2003;36:266-73. [DOI: 10.1097/00005176-200302000-00020] [Cited by in Crossref: 20] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
10 Wurm P, De Caestecker J. Emerging drugs for gastro-oesophageal reflux disease. Expert Opin Emerg Drugs 2005;10:457-71. [PMID: 15934879 DOI: 10.1517/14728214.10.2.457] [Reference Citation Analysis]
11 Scarpignato C, Pelosini I. Rifaximin, a poorly absorbed antibiotic: pharmacology and clinical potential. Chemotherapy. 2005;51 Suppl 1:36-66. [PMID: 15855748 DOI: 10.1159/000081990] [Cited by in Crossref: 132] [Cited by in F6Publishing: 128] [Article Influence: 7.8] [Reference Citation Analysis]
12 Scott LJ, Dunn CJ, Mallarkey G, Sharpe M. Esomeprazole: a review of its use in the management of acid-related disorders. Drugs. 2002;62:1503-1538. [PMID: 12093317 DOI: 10.2165/00003495-200262100-00006] [Cited by in Crossref: 101] [Cited by in F6Publishing: 83] [Article Influence: 5.1] [Reference Citation Analysis]
13 Taha AS, Angerson WJ, Morran CG. Reflux and Barrett's oesophagitis after gastric surgery--long-term follow-up and implications for the roles of gastric acid and bile in oesophagitis. Aliment Pharmacol Ther. 2003;17:547-552. [PMID: 12622763 DOI: 10.1046/j.1365-2036.2003.01430.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
14 Escobedo AA, Cimerman S. Giardiasis: a pharmacotherapy review. Expert Opin Pharmacother 2007;8:1885-902. [PMID: 17696791 DOI: 10.1517/14656566.8.12.1885] [Cited by in Crossref: 89] [Cited by in F6Publishing: 75] [Article Influence: 5.9] [Reference Citation Analysis]